These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9085037)

  • 1. Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents.
    Imanishi T; Sawa A; Ichimaru Y; Miyashiro M; Kato S; Yamamoto T; Ueki S
    Eur J Pharmacol; 1997 Mar; 321(3):273-8. PubMed ID: 9085037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats.
    Egawa T; Mishima K; Matsumoto Y; Iwasaki K; Iwasaki K; Fujiwara M
    Jpn J Pharmacol; 1997 Nov; 75(3):275-81. PubMed ID: 9434259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.
    Cumin R; Bandle EF; Gamzu E; Haefely WE
    Psychopharmacology (Berl); 1982; 78(2):104-11. PubMed ID: 6817363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
    Nagakura A; Niimura M; Takeo S
    Br J Pharmacol; 2002 Apr; 135(7):1783-93. PubMed ID: 11934820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats.
    Zhang HT; O'Donnell JM
    Psychopharmacology (Berl); 2000 Jun; 150(3):311-6. PubMed ID: 10923759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain cyclic AMP and memory in mice.
    Randt CT; Judge ME; Bonnet KA; Quartermain D
    Pharmacol Biochem Behav; 1982 Oct; 17(4):677-80. PubMed ID: 6294676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
    Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
    Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on memory in the radial-arm maze and inhibitory avoidance tests in rats.
    Zhang HT; Huang Y; Suvarna NU; Deng C; Crissman AM; Hopper AT; De Vivo M; Rose GM; O'Donnell JM
    Psychopharmacology (Berl); 2005 May; 179(3):613-9. PubMed ID: 15672274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WEB 1881 FU ameliorates impairment of working memory induced by scopolamine and cerebral ischemia in the three-panel runway task.
    Ohno M; Yamamoto T; Kitajima I; Ueki S
    Jpn J Pharmacol; 1990 Sep; 54(1):53-60. PubMed ID: 2273648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a selective cAMP phosphodiesterase inhibitor, rolipram, on methamphetamine-induced behavior.
    Iyo M; Maeda Y; Inada T; Kitao Y; Sasaki H; Fukui S
    Neuropsychopharmacology; 1995 Aug; 13(1):33-9. PubMed ID: 8526969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats.
    Sakurai T; Ojima H; Yamasaki T; Kojima H; Akashi A
    Jpn J Pharmacol; 1989 May; 50(1):47-53. PubMed ID: 2724699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase type 4 that regulates cAMP level in cortical neurons shows high sensitivity to rolipram.
    Yamashita N; Yamauchi M; Baba J; Sawa A
    Eur J Pharmacol; 1997 Oct; 337(1):95-102. PubMed ID: 9389386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism.
    Zhang HT; Crissman AM; Dorairaj NR; Chandler LJ; O'Donnell JM
    Neuropsychopharmacology; 2000 Aug; 23(2):198-204. PubMed ID: 10882846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of cAMP response element-binding activity in the aged rat brain in response to administration of rolipram, a cAMP-specific phosphodiesterase inhibitor.
    Asanuma M; Nishibayashi S; Iwata E; Kondo Y; Nakanishi T; Vargas MG; Ogawa N
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):210-5. PubMed ID: 8883954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action.
    Rutten K; Prickaerts J; Blokland A
    Neurobiol Learn Mem; 2006 Mar; 85(2):132-8. PubMed ID: 16242977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat.
    Rutten K; Lieben C; Smits L; Blokland A
    Psychopharmacology (Berl); 2007 Jun; 192(2):275-82. PubMed ID: 17265077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed treatment with rolipram protects against neuronal damage following global ischemia in rats.
    Block F; Tondar A; Schmidt W; Schwarz M
    Neuroreport; 1997 Dec; 8(17):3829-32. PubMed ID: 9427378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory.
    Barad M; Bourtchouladze R; Winder DG; Golan H; Kandel E
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):15020-5. PubMed ID: 9844008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse.
    Lenègre A; Chermat R; Avril I; Stéru L; Porsolt RD
    Pharmacol Biochem Behav; 1988 Mar; 29(3):625-9. PubMed ID: 3362958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram.
    Iyo M; Bi Y; Hashimoto K; Inada T; Fukui S
    Eur J Pharmacol; 1996 Sep; 312(2):163-70. PubMed ID: 8894591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.